Rising cancer antigen 125 level and the type and timing of treatment for recurrent ovarian cancer: a clinical dilemma, but what would women do? [electronic resource]
Producer: 20091229Description: 1037-46 p. digitalISSN:- 1525-1438
- Antineoplastic Protocols
- Biomarkers, Tumor -- blood
- CA-125 Antigen -- blood
- Decision Making
- Female
- Humans
- Neoplasms, Glandular and Epithelial -- blood
- Ovarian Neoplasms -- blood
- Patient Education as Topic
- Patient Preference -- psychology
- Recurrence
- Sentinel Surveillance
- Social Class
- Surveys and Questionnaires
- Time Factors
- Up-Regulation
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.